The kappa statistics of AAR ≤ 1 and ALT ≥ 30 IU/L in defining NASH patients was 29.4% (p = 0.201), therefore both were included in the model. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.